Why Amicus Therapeutics Stock Is Soaring Today

Keith Speights, The Motley Fool
·1-min read
Why Amicus Therapeutics Stock Is Soaring Today

Shares of Amicus Therapeutics (NASDAQ: FOLD) were soaring 9.7% higher at 12:07 p.m. EDT on Wednesday. The big gain came after Cantor Fitzgerald analyst Kristen Kluska upgraded Amicus stock to overweight from neutral. In this case, Cantor Fitzgerald's Kluska likes the prospects for Amicus because she thinks the company's gene therapy candidates are promising based on recent clinical updates.